XML 52 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Convertible Preferred Stock And Stockholders' Equity (Narrative) (Details)
1 Months Ended 6 Months Ended 12 Months Ended
May 23, 2017
shares
Sep. 29, 2016
USD ($)
shares
May 24, 2016
shares
Jun. 10, 2014
shares
Jun. 05, 2013
shares
Sep. 30, 2016
USD ($)
May 31, 2014
USD ($)
Jun. 30, 2017
USD ($)
$ / shares
item
shares
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
$ / shares
shares
Shareholders' Equity and Share-based Payments [Line Items]                    
Votes per share | item               1    
Dividends declared               $ 0    
Dividends paid               $ 0    
Proceeds from preferred stock and warrants issued, gross   $ 24,000,000                
Preferred stock, shares issued | shares   24,000                
Preferred stock, par value | $ / shares               $ 0.001   $ 0.001
Preferred Stock, Liquidation Preference, Value               $ 1,000    
Common stock issuable from warrants | shares   36,923,078                
Proceeds from preferred stocks and warrants, net                   $ 23,000,000
Payments of debt                 $ 23,709 13,000,000
Preferred stock dividend rate               6.00%    
Preferred stock, conversion price | $ / shares               $ 0.65    
Preferred stock redemption, triggering event, Percent of common stock sold threshold               50.00%    
Preferred stock, Accretion of dicount                   $ 6,100,000
Exercise price of warrants | $ / shares               $ 0.70    
Warrant term               180 days    
Increase in number of shares authorized for issuance under the Plan | shares 4,000,000   1,500,000 1,000,000 1,000,000          
Total compensation cost not yet recognized               $ 900,000    
Weighted average amortization period of total compensation cost not yet recognized               4 years    
Remaining shares available for issuance | shares               5,544,098    
Convertible Preferred Stock [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Shares converted | shares                   100
Common Stock [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Shares issued in conversion | shares                   155,439
Sales Agreement [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Aggregate gross sales price             $ 18,000,000      
Commission percentage of gross proceeds             3.00%      
Proceeds from issuance of stock                   $ 0
Warrants [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Exercise price of warrants | $ / shares               $ 0.82    
Restricted Stock Units [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Restricted shares outstanding | shares               636,862   1,167,099
Healthcare Royalty Partners Debt [Member]                    
Shareholders' Equity and Share-based Payments [Line Items]                    
Payments of debt           $ 13,000,000